Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

Latest presentation

Latest Report

February 22, 2024

Q4 Report 2023

Calendar and upcoming reports

May 3, 2024

Interim Report Q1 2024 (7:00am CEST)

May 6, 2024

Annual General Meeting

August 22, 2024

Interim Report Q2 2024 (7:00am CEST)

November 8, 2024

Interim Report Q3 2024 (7:00am CET)

Joshua’s Story

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com